Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantern Pharma Inc. - Common Stock (NQ:LTRN)

2.698 -0.152 (-5.33%)
Streaming Delayed Price Updated: 3:09 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantern Pharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)
From Lantern Pharma Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Lantern Pharma: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
From Lantern Pharma Inc.
Via Business Wire
News headline image
A Preview Of Lantern Pharma's Earnings ↗
 
Via Benzinga
News headline image
Lantern Pharma to Report Third Quarter 2023 Operating & Financial Results on November 8th, 2023 at 4:30 p.m. ET
From Lantern Pharma Inc.
Via Business Wire
News headline image
The 7 Most Undervalued AI Penny Stocks to Buy: October 2023 ↗
Unlock exponential growth with the next big undervalued AI penny stocks to buy, offering tremendous upside ahead. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Lantern Pharma to Present at the ThinkEquity Conference on October 19 at 1:30 p.m. ET
From Lantern Pharma Inc.
Via Business Wire
News headline image
Lantern Pharma Announces Publication in Clinical Cancer Research Highlighting the Enhanced Efficacy of LP-184 in Glioblastoma
From Lantern Pharma
Via Business Wire
News headline image
Lantern Pharma Announces First Patient Dosed in the Phase 1 Study for LP-184 in Advanced Solid Tumors
From Lantern Pharma Inc.
Via Business Wire
News headline image
Lantern Pharma Receives IND Clearance from FDA Enabling Phase 1 Initiation for Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas
From Lantern Pharma Inc.
Via Business Wire
News headline image
The 3 Most Undervalued Machine Learning Stocks to Buy in September 2023 ↗
Here are three machine-learning stocks that may be ready to move much higher when investor sentiment changes. 
Via InvestorPlace
News headline image
Lantern Pharma to Present Data Highlighting the Anti-Tumor Potency of Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas at the Society of Hematologic Oncology Annual Meeting
From Lantern Pharma Inc.
Via Business Wire
News headline image
3 AI Stocks That Still Trade Under $10 Per Share ↗
With the artificial intelligence (AI) boom ramping up, check out this short list of hot AI stocks under $10. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Lantern Pharma Expands AI Capabilities of RADR® Platform to Accelerate the Clinical Development of Immune Checkpoint Inhibitors
From Lantern Pharma Inc.
Via Business Wire
News headline image
The 3 Most Undervalued Machine Learning Stocks to Buy Now: August 2023 ↗
Machine learning stocks still have a lot of room left to rise despite a short-term pullback in their stock prices. 
Via InvestorPlace
News headline image
8 Best Artificial Intelligence Stocks Under $10
If you want to get in on artificial intelligence (AI) but don’t want to spend a lot, why not consider artificial intelligence stocks under $10? Learn more. 
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
The 3 Most Undervalued AI Penny Stocks to Buy Now: August 2023 ↗
Not only would I take full advantage of the pullbacks in heavyweight AI stocks, I’d also take advantage of the drops in top AI penny stocks. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Lantern Pharma Receives Notice of US Patent Allowance for Drug Candidate LP-184 for the Treatment of Rare Pediatric Brain Cancer, ATRT
From Lantern Pharma Inc.
Via Business Wire
News headline image
Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
From Lantern Pharma Inc.
Via Business Wire
News headline image
3 AI Penny Stocks With the Potential to Make Your Financial Dreams Come True ↗
These top three AI penny stocks offer immense upside ahead, potentially becoming future market leaders amid a $15.7 trillion projection. 
Via InvestorPlace
News headline image
3 AI Stocks You’ll Regret Not Buying Soon ↗
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in. 
Via InvestorPlace
News headline image
7 AI Stocks to Buy Under $5 in August 2023 ↗
These AI stocks to buy for under $5 in August have strong potential as the sector grows throughout 2023 and beyond. 
Via InvestorPlace
News headline image
RedChip Launches 'Small Stocks, Big Money' Podcast
Via ACCESSWIRE
News headline image
Lantern Pharma to Report Second Quarter 2023 Operating & Financial Results on August 9, 2023 at 4:30 p.m. ET
From Lantern Pharma Inc.
Via Business Wire
News headline image
3 AI Stocks to Buy Under $10 in August 2023 ↗
The bull market in artificial intelligence is just getting started, creating big opportunity for this list of AI stocks under $10. 
Via InvestorPlace
News headline image
7 AI Penny Stocks that Could Hit $5 Soon ↗
Here are seven AI penny stocks with huge potential as you look to make life-changing money from the advance of artificial intelligence. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Lantern Pharma to Participate and Present at Multiple Upcoming Conferences
From Lantern Pharma Inc.
Via Business Wire
News headline image
Oncotarget Publishes New Data by Lantern Pharma, an AI Company Developing Cancer Therapies, Further Supporting Clinical Advancement of LP-284, a Novel Synthetically Lethal Drug Candidate for Non-Hodgkin’s Lymphomas
From Lantern Pharma Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.